Carboplatin Intensification Beneficial for Group 3 Medulloblastoma

FRIDAY, July 23, 2021 -- For children with high-risk group 3 medulloblastoma, therapy intensification with carboplatin improves event-free survival, according to a study published online July 22 in JAMA Oncology. Sarah E. S. Leary, M.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news